Article By:
Jim Van Meerten
Thursday, January 11, 2024 11:00 AM EDT
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
In this article: IDYA